AREDS II update
This article was originally published in The Tan Sheet
Executive Summary
The National Eye Institute has enrolled 2,907 people aged 50 to 85 years with high risk of advanced macular degeneration to participate in the Age Related Eye Disease Study II, and researchers expect to complete enrollment by April, according to Dr. Traci Clemons at the SupplySide West trade show in Las Vegas Nov. 6. Clemons, senior statistician for the EMMES Corporation, the firm overseeing the study, updated seminar attendees on the the study's progress, which aims to evaluate the efficacy of lutein and zeanxanthin and/or lutein and zeanxanthin in combination with omega-3 fatty acids on progression to AMD (1"The Tan Sheet" Jan. 9, 2006, In Brief). Researchers will enroll approximately 4,000 subjects and conclude the study in 2013, five years after the last patient is enrolled...